## IFF: International Flavors & Fragrances Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%); PEG 2.24 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($63.23)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Implied Volatility Surging for International Flavors Stock Options**
- Source: TradingView â€” Track All Markets | 20251223T150759 | Neutral | Relevance: 100%
- Implied volatility for International Flavors & Fragrances Inc. (IFF) stock options is surging, particularly for the Jan. 16, 2026 $40.00 Call, indicating that the market expects a significant price movement. Analysts currently view IFF as a Zacks Rank #3 (Hold) in the Chemical - Specialty industry, and while some earnings estimates have dropped, the overall sentiment points to a potential trading opportunity due to this high implied volatility. Options traders might consider selling premium to capitalize on the expected volatility.

**2. OFI Invest Asset Management Has $25.11 Million Stock Holdings in International Flavors & Fragrances Inc. $IFF**
- Source: MarketBeat | 20251223T114305 | Bullish | Relevance: 100%
- OFI Invest Asset Management significantly increased its stake in International Flavors & Fragrances (IFF) by 92.3% in the third quarter, now holding 407,989 shares valued at $25.11 million. This makes them a substantial institutional investor in the specialty chemicals company. IFF reported strong Q3 earnings, beating analyst estimates, and has a consensus "Moderate Buy" rating from Wall Street with an average price target of $85.02.

**3. International Flavors & Fragrances Inc. $IFF Shares Sold by Douglas Lane & Associates LLC**
- Source: MarketBeat | 20251222T070901 | Neutral | Relevance: 100%
- Douglas Lane & Associates LLC reduced its stake in International Flavors & Fragrances Inc. by 19.1% during the third quarter, selling 142,686 shares and leaving them with 605,107 shares valued at $37.24 million. Despite the partial sell-off, IFF slightly surpassed quarterly earnings and revenue estimates but reported a year-over-year revenue decrease of 7.9% and a negative net margin. The company announced a quarterly dividend of $0.40 and maintains a "Moderate Buy" average analyst rating with a mean price target of $85.02.

**4. Insider Buying and Sustainable AI Investment Could Be a Game Changer For International Flavors & Fragrances (IFF)**
- Source: Sahm | 20251221T160745 | Bullish | Relevance: 100%
- International Flavors & Fragrances (IFF) recently saw a senior executive purchase shares, coinciding with increased company investment in AI-enabled, bio-based formulations for natural and sustainable ingredients. This insider buying, combined with the strategic focus on high-margin, innovation-driven products, suggests internal confidence in IFF's ability to capitalize on consumer and regulatory trends in the growing natural edible flavors and fragrances market. Despite potential risks from market weakness in North America and China, IFF's narrative projects significant earnings growth and a fair value providing a 24% upside.

**5. Bio-Tech Flavor Market Generated Opportunities, Future Scope**
- Source: openPR.com | 20251222T100927 | Somewhat-Bullish | Relevance: 94%
- The Bio-Tech Flavor Market is experiencing rapid innovation, rising investment, and shifting regional dynamics, necessitating strategic insights for decision-makers. A new report provides a comprehensive analysis of the market from 2025 to 2032, detailing segmentation by Type, Application, and Region, along with financial breakdowns of major companies like Givaudan S.A. and International Flavors & Fragrances Inc. The study aims to help businesses identify growth opportunities, target partners, and refine their strategies within this evolving landscape.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 7 ($2.72M) |
| Sells | 1 ($0.75M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Dodge & Cox Inc.: 14.4% (+5.5%)
- Vanguard Group Inc: 12.2% (+0.8%)
- Freemont Capital Pte: 9.9% (0.0%)
- Blackrock Inc.: 7.2% (-16.4%)
- State Street Corpora: 4.3% (+0.8%)

### Key Risks

1. Long-term trend broken: trading 5.7% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.24 elevated, pricing in significant growth expectations. Forward P/E 14.8x stretched relative to 5% growth. Insider buying signal ($2.7M), management confidence. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.0B |
| Beta | 1.04 |
| 52W Range | $59.14 - $88.09 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.24 |
| Forward P/E | 14.8 |
| Current P/E | 15.6 |
| YoY Growth | 4.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.9% to 1.1% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). MRS_5 (-0.7%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 54. OFD pattern: -STL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.15% (CS: 86) | Neutral |
| RSI_14 | 53.6 | Neutral |
| MACD Histogram | 0.00 | Bearish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 0.943x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $66.37
- **Stop Loss:** $63.23 (4.7% risk)
- **Target:** $69.51 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 286
- **Position Value:** $18,981.82
- **Portfolio %:** 18.98%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-17 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.02 | $1.05 | +3.3% |
| 2025Q2 | $1.12 | $1.15 | +2.5% |
| 2025Q1 | $1.14 | $1.20 | +5.7% |
| 2024Q4 | $0.82 | $0.97 | +17.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*